Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Oct;62(10):1304-1306.
doi: 10.1111/ijd.16790. Epub 2023 Jul 8.

CARD14-associated papulosquamous eruption flare-up after SARS-CoV-2 infection in a child: secukinumab a safe and effective treatment

Marco A Chessa  1   2 , Alice N Rossi  2 , Maria F Baracca  2 , Bianca M Piraccini  1   2 , Iria Neri  2
Affiliations
Comment

CARD14-associated papulosquamous eruption flare-up after SARS-CoV-2 infection in a child: secukinumab a safe and effective treatment

Marco A Chessa et al. Int J Dermatol. 2023 Oct.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Craiglow BG, Boyden LM, Hu R, Virtanen M, Su J, Rodriguez G, et al. CARD14-associated papulosquamous eruption: a spectrum including features of psoriasis and pityriasis rubra pilaris. J Am Acad Dermatol. 2018;79:487-94.
    1. Frare CP, Blumstein AJ, Paller A, Pieretti L, Choate KA, Bowcock AM, et al. CARD14-associated papulosquamous eruption (CAPE) in pediatric patients: three additional cases and review of the literature. Pediatr Dermatol. 2021;38:1237-42.
    1. Mellett M, Meier B, Mohanan D, Schairer R, Cheng P, Satoh TK, et al. CARD14 gain-of-function mutation alone is sufficient to drive IL-23/IL-17-mediated psoriasiform skin inflammation in vivo. J Invest Dermatol. 2018;138:2010-23.
    1. Kiszewski AE, De Almeida HL. Successful treatment with ustekinumab in CARD14-associated papulosquamous eruption in a Brazilian child. Dermatol Ther. 2022;35:e15939.
    1. Klein B, Treudler R, Dumann K, Boldt A, Schumann I, Simon JC, et al. Clinical response of CARD14-associated papulosquamous eruption to an anti-interleukin-17A antibody. Br J Dermatol. 2022;187:419-22.

LinkOut - more resources